Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

WuXi Biologics Pays $183 Million to Acquire Bayer German Manufacturing Facility

HitGen Delivers Candidates to Cedilla for Cancer Caused by Protein Dysregulation

WuXi Biortus Raises $15 Million for Cryo-EM Drug Discovery CRO

Pharmaron Beijing Pays Up to $137.5 Million to Acquire Absorption, a US CRO

PPD Plans Major Suzhou Lab to Offer China Drug Development Services

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China